Supernus Pharmaceuticals, Inc. (SUPN): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

57.46M

As of 2025-12-31

58.16M

As of 2026-06-30

+2.6%

3-year compound annual growth

+1.7%

5-year compound annual growth

+1.6%

10-year compound annual growth

2011-12-31 Shares Outstanding (shares) 2025-12-31

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	57.46M	+3.1%	2026-03-02, Balance as of period end
2024-12-31	55.74M	+1.9%	2026-03-02, Balance as of period end
2023-12-31	54.72M	+2.8%	2025-02-25, Balance as of period end
2022-12-31	53.26M	0.0%	2023-03-09, Balance as of period end
2021-12-31	53.26M	+0.7%	2023-03-09, Balance as of period end
2020-12-31	52.87M	+0.6%	2022-04-13, Balance as of period end
2019-12-31	52.53M	+0.4%	2021-03-08, Balance as of period end
2018-12-31	52.32M	+2.0%	2020-02-28, Balance as of period end
2017-12-31	51.31M	+2.7%	2019-03-01, Balance as of period end
2016-12-31	49.97M	+2.0%	2018-03-01, Balance as of period end
2015-12-31	49.00M	+14.0%	2017-03-16, Balance as of period end
2014-12-31	42.97M	+7.5%	2017-01-20, Balance as of period end
2013-12-31	39.98M	n/c	2015-03-12, Balance as of period end
2012-12-31	30.62M	n/m	2014-03-21, Balance as of period end
2011-12-31	1.66M	n/a	2013-03-15, Balance as of period end